Metropolitan Life Insurance CO Arbutus Biopharma Corp Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.26 - $2.92 $3,132 - $4,047	1,386 Added 46.92%	4,340 $11,000
Q4 2023 Feb 14, 2024	SELL	$1.69 - $2.54 $5,500 - $8,267	-3,255 Reduced 52.42%	2,954 $7,000
Q1 2023 May 15, 2023	SELL	$2.23 - $3.1 $856 - $1,190	-384 Reduced 5.82%	6,209 $18,000
Q4 2022 Jun 14, 2023	BUY	$1.91 - $2.85 $733 - $1,094	384 Added 6.18%	6,593 $15.4 Million
Q3 2022 Jun 14, 2023	BUY	$1.88 - $2.88 $721 - $1,105	384 Added 6.18%	6,593 $12.6 Million
Q3 2022 Mar 30, 2023	BUY	$1.88 - $2.88 $8,963 - $13,731	4,768 Added 261.26%	6,593 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $8,963 - $13,731	4,768 Added 261.26%	6,593 $13,000
Q2 2022 Jun 20, 2023	SELL	$1.98 - $3.17 $8,680 - $13,897	-4,384 Reduced 70.61%	1,825 $4,000
Q2 2022 Mar 30, 2023	SELL	$1.98 - $3.17 $7,492 - $11,995	-3,784 Reduced 67.46%	1,825 $4,000
Q2 2022 Aug 11, 2022	SELL	$1.98 - $3.17 $7,492 - $11,995	-3,784 Reduced 67.46%	1,825 $5,000
Q1 2022 Jun 20, 2023	SELL	$2.42 - $3.98 $1,452 - $2,388	-600 Reduced 9.66%	5,609 $16,000
Q1 2022 Mar 30, 2023	SELL	$2.42 - $3.98 $32,723 - $53,817	-13,522 Reduced 70.68%	5,609 $16,000
Q1 2022 May 12, 2022	SELL	$2.42 - $3.98 $32,723 - $53,817	-13,522 Reduced 70.68%	5,609 $17,000
Q4 2021 Jun 21, 2023	BUY	$3.11 - $4.61 $40,187 - $59,570	12,922 Added 208.12%	19,131 $74,000
Q4 2021 Mar 30, 2023	SELL	$3.11 - $4.61 $11,186 - $16,582	-3,597 Reduced 15.83%	19,131 $74,000
Q4 2021 Feb 15, 2022	SELL	$3.11 - $4.61 $11,186 - $16,582	-3,597 Reduced 15.83%	19,131 $74,000
Q3 2021 Jun 21, 2023	BUY	$2.65 - $4.62 $43,775 - $76,317	16,519 Added 266.05%	22,728 $97,000
Q3 2021 Mar 30, 2023	BUY	$2.65 - $4.62 $42,757 - $74,543	16,135 Added 244.73%	22,728 $97,000
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $60,229 - $105,003	22,728 New	22,728 $98,000
Q4 2018 Feb 14, 2019	SELL	$3.5 - $9.66 $9,803 - $27,057	-2,801 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$7.85 - $12.35 $51,660 - $81,275	6,581 Added 105.99%	12,790 $121 Million
Q3 2018 Nov 14, 2018	BUY	$7.85 - $12.35 $21,987 - $34,592	2,801 New	2,801 $26,000

Others Institutions Holding ABUS

# of Institutions

155

Shares Held

99.5M

Call Options Held

2.31M

Put Options Held

525K

Morgan Stanley New York, NY

21.7M
Shares

$69.2 Million
0.01% of portfolio
Whitefort Capital Management, LP New York, NY

12.9M
Shares

$41 Million
26.34% of portfolio
Black Rock Inc. New York, NY

11.6M
Shares

$36.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.92M
Shares

$28.5 Million
0.0% of portfolio
Two Seas Capital LP Rye, NY

8.39M
Shares

$26.8 Million
10.86% of portfolio

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account